Bionano Genomics, Inc. (Nasdaq: BNGO) today announced highlights from Day 3 of Bionano Symposium 2026, entitled OGM Making its Mark in Constitutional Genetic Disorders. Presentations highlighted how ...

SK bioscience announced that, together with IDT Biologika (IDT) and Australian biotechnology company Vaxxas, it has been ...

The panel ensures compatibility with our previous autosomal Family Finder tests plus all the autosomal transfers we ...

BioVenic is dedicated to advancing the advancement of veterinary molecular diagnostics through its comprehensive ...

In India, rare diseases are not so rare. It is estimated that around 70 million Indians live with one of more than 7,000 rare diseases, many of which are genetic […] ...

Background Monogenic disorders are a major cause of fetal structural anomalies. Most genetic diagnoses involve de novo, biallelic or X linked variants; however, inherited variants in autosomal ...

Florida state Rep. Adam Anderson championed the Sunshine Genetics Act, the first state-backed genetic disease screening program in the nation. Anderson's son, Drew, died in 2019 from Tay-Sachs disease ...

Testing the biological sex of an athlete is becoming more common in sport, with governing bodies defending the practice as safeguarding fairness for women. But as the introduction of mandatory genetic ...

Genetic tests make up a growing share of total spending on laboratory tests under Medicare Part B, according to a report posted last week by the Department of Health and Human Services’ Office of ...

Genetic tests make up a growing share of total spending on laboratory tests under Medicare Part B, according to a report posted last week by the HHS’ Office of Inspector General. They comprised 43% of ...

Twist Bioscience Corporation (NASDAQ:TWST) Q1 2026 Earnings Call Transcript February 2, 2026 Twist Bioscience Corporation misses on earnings expectations. Reported EPS is $-0.49946 EPS, expectations ...

NEW YORK – A report released Wednesday by the US Department of Health and Human Services Office of Inspector General found that Medicare Part B spending on clinical lab testing continued to rise in ...